Type 2 Diabetes: Insulin as a First Resort

Here is a trend that could quickly go mainstream in the treatment of many type 2s: Insulin may become a first- rather than a last-resort drug. Traditionally the initial treatment for type 2 is a sulfonylurea and metformin. In most cases, this combination offers good control from increased insulin production (sulfonylurea) and decrease in liver-produced glucose (metformin). Inevitably, though, the drugs’ effectiveness begins to taper

Read more

Metformin May Reduce Cancer Death Risk

Metformin, a commonly prescribed diabetes drug, may reduce the risk of dying from some cancers for postmenopausal women with type 2 diabetes, a new study suggests. The study found that for women with type 2 diabetes and cancer, the odds of dying from cancer appeared to be 45 percent higher compared to women with cancer who didn’t have diabetes. But, in women with cancer who

Read more

Long-term Metformin Use May Lower Colorectal Cancer Risk Among Men with Diabetes

A new study has found that the long-term use of metformin may decrease the risk for colorectal cancer among men with diabetes. This cohort study involved data from adult participants at least 40 years of age. To qualify, participants also had to have a primary diagnosis of diabetes, take a minimum of one diabetes-related medication, have a minimum of two outpatient diabetes visits, and have

Read more

No Link Between Ovarian Cancer and Metformin or Statins

A new study allows women with type 2 diabetes to breathe a sigh of relief – no connection has been found between the use of statins or metformin and ovarian cancer. This study was completed at Finland’s University of Oulu, and it examined over 137,000 women over the age of 40 diagnosed with type 2 diabetes in the country from 1996-2011. During the follow-up period,

Read more

Diabetes Health in the News Podcast: Metformin Best For Heart Safety

Metformin is the most frequently prescribed standalone medication for the treatment of type 2 diabetes. Now, a new study has found that this drug is actually better for the heart than most of its closest competitors. This result came after analyzing over 200 studies that involved 1.4 million people. The findings suggest that Metformin reduced the risk of suffering a fatal heart attack or stroke

Read more

Living With Type 2 Diabetes: Metformin Safer For Heart Than Other Meds

MONDAY, April 18, 2016 (HealthDay News) — Metformin, the most frequently prescribed standalone drug for type 2 diabetes, is better for the heart than its closest competitors, a large analysis suggests. Metformin reduced the risk of dying from heart attack and stroke by about 30 percent to 40 percent compared with other commonly used drugs called sulfonylureas, such as glibenclamide, glimepiride, glipizide and tolbutamide, researchers

Read more

Living With Type 2 Diabetes: Januvia Is A Better Option

Those diagnosed with diabetes before 2011 have likely experienced the debilitating effects of Metformin. The churning stomach, horrendous gas, and the overall feeling of sickness makes you wonder if the pain is worth the reward. Things got so bad for me that I stopped taking the medicine due to the uncomfortable side effects. As far as I am concerned, Metformin should be banned. Well, there’s

Read more

What Is Diabetes?

You’ve been diagnosed with diabetes because there is too much glucose (a kind of sugar) in your blood. Glucose comes from the starches and sugars that you eat. (However, diabetes is not caused by eating too much sugar.) Your muscle and fat cells use glucose for energy. But glucose can’t just float into your cells. It has to be helped into your cells by insulin,

Read more

Diabetes Health in the News Podcast: Metformin Linked to Vitamin B12 Deficiencies and Neuropathy

https://media.blubrry.com/diabeteshealthpodcast/p/www.diabeteshealth.com/wp-content/uploads/2015/12/Nov-18_-2015_-11_34_15-PM.m4aPodcast: Play in new window | DownloadClick here to listen to today’s Diabetes Health in the News Podcast! Dutch researchers have recently conducted a study to see how treating diabetes with metformin could affect vitamin B12 deficiencies and neuropathy. The study consisted of two groups: the first group was taking 850mg of metformin three times a day for a total of 52 months while the

Read more